leukotriene D4

PubChem Notes:

Leukotriene D4 One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990)

Molecular Formula: C25H40N2O6S


InChI: InChI=1/C25H40N2O6S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-22(21(28)15-14-17-23(29)30)34-19-20(26)25(33)27-18-24(31)32/h6-7,9-13,16,20-22,28H,2-5,8,14-15,17-19,26H2,1H3,(H,27,33)(H,29,30)(H,31,32)/b7-6-,10-9-,12-11+,16-13+/t20-,21-,22+/m0/s1/f/h27,29,31H

InChIKey: InChIKey=YEESKJGWJFYOOK-MBFKQSLNDJ
SMILES: CCCCC\C=C/C\C=C/C=C/C=C/[[email protected]@H](SC[[email protected]](N)C(=O)NCC(O)=O)[[email protected]@H](O)CCCC(O)=O

Names:
    CHEBI:28666
    leukotriene D4
    Leukotriene D4
    leukotriene D4
    LTD4
    S-{(1R,2E,4E,6Z,9Z)-1-[(1S)-4-carboxy-1-hydroxybutyl]pentadeca-2,4,6,9-tetraen-1-yl
    (R-(R*,S*-(E,E,Z,Z)))-N-(S-(1-(4-Carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)glycine
    (R-(R*,S*-(E,E,Z,Z)))-N-(S-(1-(4-Carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-
    (5S,6R,7E,9E,11Z,14Z)-6-[(2S)-2-amino-2-(carboxymethylcarbamoyl)ethyl]sulfanyl-5-hydroxy-icosa-7,9,11,14-tetraenoic acid
    5S-hydroxy-6R-(S-cysteinylglycinyl)-7E,9E,11E,14Z-eicosatetraenoic acid
    73836-78-9

Registries:
    PubChem CID 5280878
    ChEBI 28666
    LIPID MAPS LMFA03020006
    PubChem ID 14717707